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Abstract 
 
Aim: The aim of this study was to compare different screening modalities in the detection of 
PAD in a primary care setting.  
 
Methods: Fifty participants living with Type 2 diabetes were recruited. Pulse Palpation, 
waveform analysis, ankle brachial pressure index, absolute toe pressure, toe brachial pressure 
index and transcutaneous oxygen pressure were compared in the detection of peripheral arterial 
disease. One hundred limbs were included for analysis. 
 
Results: This study showed different results in peripheral arterial disease screening tests in 
the same group of participants.  The highest percentage of participants who had PAD was for 
the Doppler Waveform (93.0%). This was followed by TBPI (72.0%), ABPI (57.0%), ATP 
(35.0%), TCPO (30.0%) and Pulse Palpation (23.0%). The difference between these 
percentages is significant (p<0.0005). The magnitude of the effect size is medium/moderate 
(Cramer's V=0.498). 
Conclusion: This study demonstrates that inconsistencies exist between the agreement of 
the 6 different modalities used to detect PAD. These findings should create an awareness 
amongst clinicians when interpreting results of these tests. The authors advocate for urgent, 
more robust studies utilizing a gold standard modality for the diagnosis of PAD in order to 
provide evidence regarding which screening modalities would yield the most valid results.  
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1.0 Introduction 
 
 
Diabetic foot disease is amongst one of the most feared complications of diabetes [1]. It is of 
global concern, being the leading cause of lower limb amputations [2] which results in reduced 
quality of life, and hospitalization, incurring a considerable financial burden [2]. 
Peripheral Arterial Disease (PAD) refers to the formation of atherosclerotic plaques in the 
blood vessels of the lower limbs. This results in reduced blood flow to the effected limbs and 
is a major risk factor for chronic foot ulcers and for lower limb amputations especially in 
individuals living with diabetes [3]. Patients with diabetes have a 2 – 3-fold increased risk of 
developing atherosclerosis [1,4]. For every 1% increase in HBA1c there is a corresponding 
26% increased risk of developing PAD [5]. For these reasons, early diagnosis of PAD in people 
living with diabetes is imperative [6]. 
The real prevalence of PAD in patients with diabetes has been proven difficult to determine 
since most patients are asymptomatic [7] and approximately one half of the individuals living 
with PAD, remain undiagnosed. This is a result of two main factors; either because the 
individual is asymptomatic or has atypical symptoms or else because the health care 
professionals make use of poorly-validated methods of screening for PAD, such as pulse 
palpation or history of intermittent claudication. Most importantly, literature presents issues 
[2,6] with regards to the validity of the current screening techniques commonly used in 
assessing lower limb perfusion, such as pulse palpation, which is subjective, calculation of 
ABPI and TBPI where their results is debateable due to the influence of peripheral neuropathy 
and arterial calcification and the accuracy of waveform analysis alone, since although reported 
as having high inter-rater reliability, the validity of this test remains unclear. 
  
Broad interest exists in improving the quality of primary health care, not only among clinicians 
and patients but also among politicians and insurers, therefore,  since early correct diagnosis 
of PAD is crucial in the diabetic population [6], especially amongst asymptomatic patients 
presenting at primary care to prevent diabetic foot complications and lower limb amputations 
[8].  Literature suggests the need to correctly optimize the diagnosis of PAD especially in non-
specialist settings such as primary care [9] where there could be the possibility that clinicians 
differ in their screening and diagnostic skills when compared to a vascular specialist.  Effective 
long term care of patients with PAD requires an increase in diagnostic efforts within the clinical 
setting to decrease ischemic complications, systemic cardiovascular risk and improve quality 
of life [10].  
In 2011, Stephens et al. reported that the general practice for detecting PAD was mainly 
focused on pulse palpation, physical examination, history taking and patient reporting 
symptoms of intermittent claudication, the same methods of assessment for PAD which were 
used back in 1996 [11]. Although there is vast knowledge with regards to PAD, there seems to 
be lack of knowledge and consensus regarding the best method of assessment of PAD in 
patients living with diabetes [12,13].   
 
This gap in knowledge and the need for identifying the most appropriate method to accurately 
detect PAD has prompted the need to conduct this study. This research sought to compare 6 
most commonly used clinical tools for diagnosis of PAD in the lower limbs, i.e. foot pulses, 
ankle brachial pressure index, toe brachial pressure index, spectral doppler waveform analysis, 
absolute toe pressure and transcutaneous oxygen perfusion (TcP02), to look for agreement 
between them making this study the first to directly compare these 6 different modalities.  
  
  
2.0 Materials and Methods  
A prospective non-experimental comparative study was conducted. Fifty participants living 
with Type 2 diabetes were recruited using a convenience sampling method. This study was 
approved by the University Research Ethics Committee and all participants provided informed 
consent before any data collection. All investigations were carried out in accordance with the 
principles of the Declaration of Helsinki as revised in 2000. Adults diagnosed with type 2 
diabetes mellitus were recruited. Participants were excluded if they presented with open 
wounds which contraindicate compression and which could interfere with the assessment, 
foot/lower limb oedema, lower extremity amputation, history of revascularisation procedures 
of the lower limbs, conditions which contradict compression, a history of DVT in the previous 
6 months, not being cognitively alert or showing unwillingness to participate in the study. 
 
The testing modalities and examination methods were carried out by same investigator to 
ensure inter-rate reliability. The screening process involved review of the patient’s medical 
history and a lower-extremity physical examination. Each individual’s personal lifestyle 
characteristics and clinical history including duration of diabetes, recent HbA1c, weight, 
height, current medications, smoking history were recorded.  History of hypertension, 
hyperlipedaemia, ischemic related changes to the foot such as hair loss; atrophic, shiny skin 
were also noted. 
 
All participants were assessed for PAD using the 6 different modalities described below, in 
random order. The right and left foot were assessed in each participant, therefore 100 limbs 
were included for analysis. Room temperature was maintained at 21 to 23 degrees Celsius (68 
to 75oF) during the assessments to avoid vasoconstriction of digital arteries from the cold. 
Participants were rested in the supine position and acclimatized for 20 minutes prior to testing. 
  
 
2.1 Pedal Pulse Palpation  
Palpation of the foot pulses; namely the dorsalis pedis; which is located on the dorsal aspect of 
the foot between the first and second metatarsals; and  the posterior tibial; which is located 
behind the medial malleolus were assessed. This assessment was conducted by an experienced 
vascular clinician. The feet were also examined to check for any changes such as: colour, pallor, 
cyanosis; extreme change in temperature gradient (colder distally); hair anomalies and 
atrophic, shiny, dry skin. Pulses were classified as present or absent. Absent pulses denoted 
presence of arterial disease. 
 
2.2  Spectral Doppler Waveform Analysis and ABPI Measurements 
Measurement of ABPI was performed using a portable hand held Doppler and blood pressure 
cuffs. Pedal spectral waveform analysis of the dorsalis pedis  and the posterior tibial were 
acquired from all recruited subjects utilizing a Huntleigh® Dopplex Assist vascular package 
(Cardiff, UK) with an 8MHz probe. The probe was held steadily on the anatomical artery 
location at an angle between 45 to 60 degrees against the flow of arterial blood. Interpretation 
of arterial pressure waveforms results was based on standards from the literature [5]. 
Waveforms were classified as triphasic, biphasic, monophasic discontinuous and monophasic 
continuous. The triphasic waveforms were considered as normal, whereas the biphasic and 
monophasic discontinuous and monophasic continuous waveforms were interpreted as 
abnormal.  
Participants received instructions refrain from smoking and caffeine intake prior to data 
collection. Measurements were carried out after a 5-minute rest in supine position with the 
upper body as flat as possible, with all tight clothing around the waist and the arm undone.  
A blood pressure cuff was applied to the arm [to measure the brachial systolic pressure] and 
the ankle [to measure the dorsalis pedis and posterior tibial pressures] to determine the ankle 
  
pressure. The systolic pressure was noted and the higher values of the brachial and the ankle 
pressures were used to calculate the ABPI. Values were interpreted according to the criteria 
proposed by the American Heart Association and the American Diabetes Association [14]. 
ABPI calculations were interpreted as 0.9– 1.29 normal, lower-extremity vascular disease was 
defined an ankle brachial index < 0.90 in either foot. An ABPI of >1.3 was considered 
significantly elevated and indicative of vascular calcification. 
 
2.3  Toe Pressures – ATP and TBI 
The procedure for obtaining toe pressures and TBI’s involved applying a 1.5cm cuff on the 
proximal aspect of the hallux or 2nd toe and the photopletysmography probe was applied on the 
pulp of the hallux. Patients were examined in the supine position. When a regular waveform 
was observed, the sphygmomanometer was pumped up slowly to inflate the digital cuff and 
occlude digital blood flow, to a maximum of 200 mmHg. Upon slow release, the point at which 
the waveform was observed the toe systolic pressure was measured. Using PPG, the actual TBI 
was obtained during gradual deflation of the cuff at the moment the pulsatile signal reappeared. 
Toe pressures and the TBI were automatically calculated by the dopplex unit.  
For ATP results ranging from 75mmHg – 130mmHg were considered as not having PAD, 
whilst any results =<74mmHg were considered as an indication of periphera arterial disease 
(Kapur 2015).  Participants with a TBPI ratio >0.7 were diagnosed as not having PAD, whilst 
those with a ratio of <0.7 were diagnosed with PAD (weinberg, 2012) 
 
2.4  TcPO2 
The TcPO2 measurement was carried out with the use of a Perimed PeriFlux 6000 machine 
(Perimed , 2017). The electrode, placed on the  dorsal, tibial aspect of the midfoot, was 
  
calibrated automatically by the machine itself. Prior to calibration, the site of assessment was 
cleaned with alcohol after the removal of any hair growth.  
 
A standard fixation ring was applied securely to the prepared site. The hole of the fixation ring 
was filled with contact liquid and the electrode was fixed into the ring. 
 
Following the electrode fixation, a waiting time of 15 – 20 minutes was allowed for 
physiological stabilization. During this time, the electrode slowly heated the skin to  vasodilate 
the arteries which is necessary to do the tcpO2 reading. Following the physiological 
stabilisation, the machine continued to perform the tcpO2 readings automatically.  
 
Participants with a TcPO2 reading =\>50mmHg were classified as having no PAD, whilst those 
with a reading below this value were diagnosed as having PAD (REF). 
 
For the purposes of data analysis, each foot was scored separately resulting in 100 limbs for 
analysis. All data was recorded on a spreadsheet designed in Microsoft Excel to group together 
the information required for interpretation of the results. The IBM SPSS (Statistical Package 
for Social Sciences) (Version 25) program was utilized for the statistical analysis. The Chi 
Square test was used to assess the association between two categorical variables. One of these 
variables was peripheral arterial disease (Present versus Absent) while the other variable 
included the instruments used (Pulse Palpation, waveform analysis, ankle brachial pressure 
index, absolute toe pressure and transcutaneous oxygen pressure). The null hypothesis 
specified that there is no association between the two categorical variables and was accepted if 
the p-value exceed the 0.05 level of significance.  
 
 
  
3.0 Results 
A total of 50 participants with type 2 diabetes, 14 males and 36 females, mean age of 71.1 
years, mean duration of diabetes, 18.82 years and mean weight 79.94kg, were included in the 
study.  
The highest percentage of participants that were positive for PAD was reported by the Doppler 
Waveform (93.0%). This was followed by TBPI (72.0%), ABPI (57.0%), ATP (35.0%), 
TCPO2 (30.0%) and Pulse Palpation (23.0%). On the other hand, the highest proportion of 
respondents that did not have PAD was for the Pulse Palpation (77.0%), followed by TcPO2 
(70.0%), ATP (65.0%), ABPI (43.0%), TBPI (28.0%) and Doppler Waveform (7.05). The 
difference between these percentages is significant (p < 0.0005).  
 
The Cramer’s V is a test that can be used to yield an estimation of the magnitude of the 
association between the variables.  Therefore, this test was used to determine the strength of 
the association between the 6 modalities for the assessment of PAD used in this study. 
According to Cramer's V , the strength (or magnitude) of association between the two variables 
is moderate (Cramer's V = 0.498). 
 
Insert Table 1 and Figure 1  
 
4.0 Discussion 
This study sought to compare the agreement of commonly-used non-invasive clinical tests 
utilized for the detection of PAD including pulse palpation, waveform analysis, ankle brachial 
pressure index, absolute toe pressure, toe brachial pressure index and transcutaneous oxygen 
pressure in subjects living with Type 2 diabetes mellitus.  
 
  
There is an extensive amount of literature available concerning various screening methods for 
PAD, however to date there is no definite evidence on whether in fact, the results of these tests 
concur with each other. This proves to be a major concern since PAD is considered as one of 
the most dangerous complication of diabetes that increases the likelihood of ulceration and 
amputation.  
 
Current study, whilst seeking to provide this required evidence, clearly demonstrates  
substantial inconsistencies between these 6 different screening/diagnostic modalities for PAD. 
One might argue that the major limitation of this study is that the 6 test results were not 
compared to a ‘gold standard’ test for PAD such as conventional angiogram or CT Angio, 
however this is the first study which has quantitatively compared all the presently available 
clinical tests for arterial perfusion. Results from pulse palpation reports the least presence of 
PAD (23%)  and doppler waveform the highest (93%). Although one could argue that we are 
unable to determine  the actual incidence of PAD in the study  population since they were not 
investigated utilizing a gold reference as highlighted above, the main purpose of this paper is 
to compare commonly used clinical measurement techniques. These are the techniques used in 
everyday clinics around the world to make clinical decisions and to develop clinical 
management plans.   
 
The findings reported within this paper have important implications for both clinical practice 
and future research. The reported observations suggest that use of only one screening tool in 
isolation, could yield high false results since it is clear that these tests do not concur with each 
other to a large extent.  Although the use of more specialized investigations such as duplex 
scanning could be compared with the six modalities to detect PAD that this study focused on, 
it was beyond the scope of the reported investigation. This was mainly attributed to the frontline 
  
assessment carried out at the primary care level, with the main criteria being easier availability 
to the general medical practitioner. A future study could build on our results to identify the 
right modality which will be beneficial for the community. 
 
The authors postulate that one possible reason for the increase of both minor and major 
amputations worldwide could be the untimely and/or incorrectly diagnosed PAD due to 
inconsistency exhibited between these 6 widely used tests. Patients who are falsely identified 
as having no PAD when indeed this could be present could pose a threat to this high risk 
population since if they are not appropriately detected, they would be denied early beneficial 
and effective secondary risk factor control together with further investigations to determine the 
extent of the condition. Furthermore, accurate diagnosis also safely reduces unnecessary 
secondary care referrals when it is known that these appointments could be utilized by those 
patients who truly have the condition and are denied of prompt attention due to long waiting 
lists. 
 
We recommend that those practitioners who are clinically responsible for patients should be 
made aware of these inconsistencies, and possibly advised to use alternative methods of 
diagnosis, such as more detailed clinical evaluation and/or imaging modalities. Findings from 
this study have created an urgent need for replicating this study utilizing a reference standard 
modality for the diagnosis of PAD in order to provide sufficient evidence as to which tool 
should be utilized for the screening and diagnosis of this common condition which is often 
managed by the clinician in a primary care or general practice setting.  
 
 
5.0 Conclusion 
 
  
Correct diagnosis of PAD in patients with diabetes is crucial.  This study demonstrates that 
inconsistencies exist between the agreement of the 6 different modalities used to detect PAD. 
These findings should create an awareness amongst clinicians and researchers in the field, with 
regards to caution when interpreting results of these tests. The authors advocate for urgent, 
more robust studies utilizing a gold standard modality for the diagnosis of PAD in order to 
provide evidence regarding which non-invasive screening modalities would yield the most 
valid results. This would significantly reduce the proportion of patients with diabetes who 
would be falsely identified as having no PAD and subsequently denied beneficial and effective 
secondary risk factor control. 
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Figure 1: Presence/absence of PAD using the different physiological tests (n=100 limbs) 
χ²(5) = 148.939, p < 0.0005, Cramer's V = 0.498  
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